There have already been several attempts targeting IGF1 signaling in clinical trials [66, 100], but the therapeutic effects in patients with heart failure are controversial [101–105].Moreover, uncontrolled activation of the IGF1 pathway may cause tumorigenesis in other organs [106, 107]. Here, IGF1 is linked to heart failure.